Drug Profile
Research programme: GPCR modulators - cue BIOtech/Lundbeck A/S
Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator cue BIOtech; Lundbeck A/S
- Class
- Mechanism of Action G protein-coupled receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported CNS disorders
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in CNS-disorders in USA
- 27 Jan 2006 Preclinical trials in CNS disorders in USA (unspecified route)